The Nalu Neurostimulation System
Small Size Without Compromise

Our micro-Implantable Pulse Generator (mIPG)

named 2021 Implant and Tissue-Replacement device Gold Winner, Medical Design Excellence Awards

Small device, BIG IMPACT on pain relief

Traditional neuromodulation SCS systems require larger incisions and surgeries for replacing implantable batteries. At Nalu, we offer a fully-featured, battery-free, miniaturized implantable pulse generator, or IPG, which is powered by an externally worn battery (therapy disc) and controlled through a smartphone based remote control app.

Up to 27 times smaller than the largest commercially available implantable pulse generator
Nalu Neurostimulation System with nPower™ Technology
Implants
  • Battery-free to eliminate
    implanted battery and need for
    battery replacement.
  • 27 times smaller than the largest
    commercially available
    implantable pulse generator.
  • Requires minimally invasive
    procedure for implantation.
  • IPG can be removed or
    discontinued by physician
    if desired.
Peripherals
Smartphone Remote Control App
  • Enable easy and discreet therapy adjustments.
  • Capable of delivering a wide range of therapy
    options.
  • Compatible with iOS and Android smart-phones.
Therapy Disc (Your external battery power and control)
  • Removable when not needed or desired.
  • Easily upgradable or replaceable without surgery
    when appropriate.
Indications

The Nalu Neurostimulation System is currently FDA cleared for SCS and PNS indications.

Spinal Cord Stimulation (SCS)

This system is indicated as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach for chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain. The trial devices are solely used for trial stimulation (no longer than 30 days) to determine efficacy before recommendation for permanent (long term) device.

Peripheral Nerve Stimulation (PNS)

This system is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. The Nalu Neurostimulation System for PNS is not intended to treat pain in the craniofacial region. The trial devices are solely used for trial stimulation (no longer than 30 days) to determine efficacy before recommendation for permanent (long term) device.

All information on this website is provided for informational purposes only and is not a substitute for any professional medical advice. No information contained on the website is intended to be used for medical diagnosis or treatment.